- Differentiate between the two most common forms of cardiac amyloidosis.
- Describe the current therapeutic landscape for AL amyloidosis.
- Describe the current and likely future therapeutic landscape for ATTR amyloidosis.
06/24/2022 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Ronald Witteles, MD